Wide variability in the sensitivity of APTT reagents for monitoring of heparin dosage.
AUTOR(ES)
Kitchen, S
RESUMO
AIM: To assess the sensitivity of activated partial thromboplastin time (APTT) reagents for monitoring heparin dosage using data from the UK National External Quality Assessment Scheme (NEQAS) for blood coagulation. METHODS: Data were reviewed from four surveys using samples prepared by addition of heparin to normal plasma in vitro and from two surveys in which samples were prepared using plasma from patients receiving heparin therapy (ex vivo samples). RESULTS: For both in vitro and ex vivo samples, notable differences between APTT reagents with respect to heparin sensitivity were noted. This indicates that a uniform therapeutic range of 1.5-2.5 calculated by the APTT ratio may not be appropriate for all reagents. Reagent sensitivity in ex vivo samples was substantially different to that in in vitro samples. CONCLUSIONS: The results of this large series of laboratories clearly indicate that reagent specific therapeutic ranges may be necessary, and that samples prepared by the addition of heparin to normal plasma in vitro can be misleading and should not be used.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1023149Documentos Relacionados
- Venous thromboses in myocardial infarction. Comparison in heparin dosage.
- Expression of the gene for ribosomal protein S20: effects of gene dosage.
- Use of plasma levels in evaluation of procainamide dosage.
- High dosage procaine penicillin combined with ampicillin in the treatment of gonorrhoea after failure with standard procaine penicillin dosage.
- Response of acute cerebral lupus in childhood to pulse methylprednisolone in reduced dosage.